Bank of Montreal’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,300
Closed -$389K – 4021
2026
Q1
$389K Buy
+3,300
New +$461K ﹤0.01% 2514
2024
Q1
– Sell
-8,100
Closed -$1.52M – 4250
2023
Q4
$1.52M Buy
+8,100
New +$1.26M ﹤0.01% 1830

Other funds holding RGEN

Bank of Montreal's RGEN Position: Q2 2026 in Review

Bank of Montreal reduced its Repligen (RGEN) stake by 15% in Q2 2026, selling an estimated $447K and leaving 20,025 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

Bank of Montreal first reported a position in RGEN in Q2 2013 and has held it in 53 quarters since. The position peaked at $39.7M in Q1 2023. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Bank of Montreal held 20,025 shares of Repligen worth $2.73M as of Q2 2026.
  • Bank of Montreal sold 3,642 Repligen shares in Q2 2026, an estimated $447K.
  • Repligen made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1605 holding.
  • Bank of Montreal first reported a position in Repligen in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Repligen position peaked at $39.7M in Q1 2023.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.